Alphatec Spine Reports $49.7M in Q1 Revenue, 40.9% Increase

Spinal Tech

Alphatec Spine, a Carlsbad, Calif.-based spine device company, reported first quarter revenue of $49.7 million, which represents a 40.9 percent growth over the first quarter of 2010, according to a company news release.

Dirk Kuyper, Alphatec Spine president and CEO, attributes the company's success to a successful showing in the Japanese, Asian Pacific and Latin American markets in addition to the United States. During this quarter, the company received a boost from increasing sales of the PureGen product and the FDA clearance of the Solus anterior lumbar interbody fusion system.

The domestic market contributed $33.9 million to the company's overall revenue, and its international revenue more than doubled since the first quarter of last year, representing $15.9 million. The company plans on focusing efforts on laser technology for the aging spine, minimally invasive procedures and biologics to gain a global share of the spine market, Mr. Kuyper said in the report.

Read the release on the financial results from Alphatec Spine.

Read Articles Related to Alphatec Spine:
Alphatec Spine Signs Agreement With Merlot OrthopediX for Spine Surgery Technology

Alphatec Holdings Names Former Johnson & Johnson Exec New CFO
Alphatec Spine Receives 510(k) Clearance for Solus System





Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers